Addition of long‐acting beta2‐agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children
FM Ducharme, MN Chroinin… - Cochrane Database …, 2010 - cochranelibrary.com
Background Long‐acting inhaled ß 2‐adrenergic agonists (LABAs) are recommended as'
add‐on'medication to inhaled corticosteroids (ICS) in the maintenance therapy of asthmatic …
add‐on'medication to inhaled corticosteroids (ICS) in the maintenance therapy of asthmatic …
Regular treatment with formoterol for chronic asthma: serious adverse events
CJ Cates, MJ Cates… - Cochrane Database of …, 2008 - cochranelibrary.com
Background Epidemiological evidence has suggested a link between beta‐agonists and
increases in asthma mortality. There has been much debate about possible causal links for …
increases in asthma mortality. There has been much debate about possible causal links for …
Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled …
HAM Kerstjens, TB Casale, ER Bleecker… - The Lancet …, 2015 - thelancet.com
Background In patients with severe asthma, tiotropium improves lung function and
exacerbation risk when added to high-dose inhaled corticosteroids plus long-acting β 2 …
exacerbation risk when added to high-dose inhaled corticosteroids plus long-acting β 2 …
Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised …
M Patel, J Pilcher, A Pritchard, K Perrin… - The Lancet …, 2013 - thelancet.com
Summary Background The Single combination budesonide–formoterol inhaler Maintenance
And Reliever Therapy (SMART) regimen reduces severe asthma exacerbations in patients …
And Reliever Therapy (SMART) regimen reduces severe asthma exacerbations in patients …
Inhaled corticosteroids and risk of upper respiratory tract infection in patients with asthma: a meta-analysis
M Yang, Y Zhang, H Chen, J Lin, J Zeng, Z Xu - Infection, 2019 - Springer
Background Recent studies have suggested a possible association between respiratory
infection and the use of inhaled corticosteroids (ICS). We aimed to ascertain the risk of upper …
infection and the use of inhaled corticosteroids (ICS). We aimed to ascertain the risk of upper …
The safety of long-term use of inhaled corticosteroids in patients with asthma: a systematic review and meta-analysis
W Shang, G Wang, Y Wang, D Han - Clinical Immunology, 2022 - Elsevier
Purpose This systematic review and meta-analysis was performed to determine the safety of
long-term use of ICS in patients with asthma. Methods A systematic search was made of …
long-term use of ICS in patients with asthma. Methods A systematic search was made of …
Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?
E Festic, PD Scanlon - American journal of respiratory and critical …, 2015 - atsjournals.org
Inhaled corticosteroids are commonly prescribed for patients with severe chronic obstructive
pulmonary disease. Although their use improves quality of life and reduces exacerbations, it …
pulmonary disease. Although their use improves quality of life and reduces exacerbations, it …
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events
CJ Cates, R Jaeschke, S Schmidt… - Cochrane Database of …, 2013 - cochranelibrary.com
Background Epidemiological evidence has suggested a link between beta 2‐agonists and
increases in asthma mortality. Much debate has surrounded possible causal links for this …
increases in asthma mortality. Much debate has surrounded possible causal links for this …
Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review
GJ Rodrigo, VP Moral, LG Marcos… - Pulmonary …, 2009 - Elsevier
BACKGROUND: Safety of long-acting beta agonists (LABA) has been questioned and
recent evidence suggested a detrimental effect on asthma control as well as an increased …
recent evidence suggested a detrimental effect on asthma control as well as an increased …
[HTML][HTML] Safety of as-needed budesonide-formoterol in mild asthma: data from the two phase III SYGMA studies
Introduction Budesonide-formoterol taken as needed is an emerging treatment for mild
asthma. Objective We used data from the SYGMA studies to assess the safety of As-needed …
asthma. Objective We used data from the SYGMA studies to assess the safety of As-needed …